Background: Routine comparable outcome data collection relating to the later health status of babies born very preterm has long been considered important but has not been achieved in the UK.
INTRODUCTION
There has been a longstanding acceptance by the neonatal clinical community that increased survival of the sickest and most immature babies might be associated with significant rates of long-term morbidity. As a consequence there are large numbers of published reports providing snapshots of later outcomes following preterm birth. However, lack of standardisation of approach in these studies has made it difficult to establish a clear perception of what constitutes good or poor performance in terms of the overall outcomes for graduates of neonatal intensive care.
In contrast, interest in the concept of formal care quality assessment is relatively recent in the UK having largely followed the reorganisation and separation of the processes of commissioning and delivery of care in the 1990s. Whilst this has increased the desire for on-going data about later health status of high risk newborns 1 both the cost of introducing formal assessments of health and development in childhood and the lack of standardisation in defining outcomes have hindered progress.
In 1993, an Audit Commission report 2 highlighted the lack of outcome data for babies discharged home from neonatal care. In response, a major initiative was launched to establish a simple standardised system for measuring later health status in high-risk babies 3 . The subsequent report aimed to define, for each of the main areas of health and development, characteristics that represented severe disability. For assessing cognitive impairment it recommended a cut-off of 2 standard deviations for defining impaired function and below 3 standard deviations for the definition of severe cognitive impairment, using any well validated test. During the 1990s it became clear that a simple, inexpensive and effective means of assessing cognitive development was required for population screening and for research-based outcome evaluations. This led to the development of parental questionnaires as cost-efficient methods of first-line screening. To date, the Parent Report of Children's Abilities-Revised (PARCA-R), designed for use at two years corrected age, has been the most widely used in preterm populations, mainly as an outcome measure in randomised trials 4 5 . Assessment at two years is widely accepted as the first opportunity at which overall health and cognitive status can be reliably measured.
Our study explored the use of a parent report version of the Oxford minimum dataset and PARCA-R as a cost-effective means of providing routine follow-up data at two years corrected age. Specifically, we wished to know whether:
A postal questionnaire to parents would be an effective way of obtaining routine data on neurodevelopmental outcomes in babies from high risk categories that would be suitable for quality improvement purposes.
(ii) A postal questionnaire to parents would be an effective way of screening babies from high risk categories for evidence of impaired health status at 2 years.
METHOD
The PANDA (Preterm AND After) study was based in the East Midlands and Yorkshire regions of England, which account for approximately 15% of UK births. All neonatal intensive care admissions in these regions were captured by The Neonatal Survey between 2004 and 2014 6 . In 2009, the Commissioning Groups for these regions agreed to fund an exploratory investigation of the use of a parent questionnaire, which combined the PARCA-R and additional questions to classify motor and sensory disability based on the Oxford minimum dataset, for clinical outcome assessment in all infants born at ≤30 weeks of gestation. This gestational age group was chosen because it would include babies at greatest risk of adverse outcome but also ensured that the number of babies included (approximately 1% of births) remained manageable.
The Trent Multi-centre Research Ethics Committee gave approval, designating the project as meeting the criteria for research. It was therefore necessary to obtain written consent from the parents of all eligible babies.
Sole reliance on prospective data collection would have incurred a delay of over three years before data on outcomes at two years (based on a full year of births ≤30 weeks of gestation) could be reported to commissioning bodies. We therefore used two different approaches in parallel: 1) Retrospective identification. Funding commenced in 2009. All cases born in 2007 and 2008 and eligible for inclusion in terms of birth address and gestation were identified from The Neonatal Survey. After checking the vital status of all babies with the NHS central register, consultants were contacted in the hospitals from which these babies were discharged following neonatal care. They were asked to send a standard letter to parents seeking their consent to be involved in the questionnaire follow-up. One reminder was sent to non-respondents.
2) Prospective identification. During 2009 to 2011, neonatal units discharging eligible babies were asked to obtain consent from parents for participation in the PANDA follow-up project. Although we encouraged clinical teams to gain consent before discharge, some preferred to use their neonatal outreach service to gain consent after discharge. During the final year of data collection this work was included in the National Institute of Health Research (NIHR) research portfolio (as part of a larger EU FP7 project), which meant that hospitals received a financial benefit for recruitment.
A single part time administrator ran the project from The Infant Mortality and Morbidity Studies (TIMMS) office at the University of Leicester.
As all eligible babies were born preterm their second birthday fell before a corrected age of two years and a note informing parents that the assessment forms would soon arrive was sent with a 2 nd birthday card where possible. The study questionnaire and a reply paid envelope were then sent with instructions asking parents to complete the questionnaire as close as possible to the identified date on which the child would reach two years corrected age. Paper forms were used for data collection and one reminder was sent by post if the forms were not returned after three to six weeks.
Measures
The questionnaire consisted of two sections. The first was a parent report adapted from the Oxford minimum dataset (Table 1) . Parents were asked to rate their child's health and development using forced-choice questions corresponding with the Oxford minimum dataset domains so that severe disability could be classified in each domain.
To assess cognitive development, we used the PARCA-R parent questionnaire. This is designed to assess non-verbal cognitive and language development in preterm infants at two years corrected age. From this, the total Parent Report Composite (PRC) score, which combines non-verbal cognition and the linguistic skills sub-scale scores, was used to assess cognitive function. PRC scores can range from 0 to 158, with lower scores representing poorer performance, and a PRC score of less than 49 was originally recommended to identify moderate/severe delay, equivalent to test scores < -2SD 7 .
. A number of studies have explored the validity of the PARCA-R and have produced slightly different cut-off scores with optimum diagnostic utility for identifying moderate/severe developmental delay [7] [8] [9] [10] . We opted to use a cut-off of <44 as identified in Johnson et al 2008 8 . This was derived from a large validation study of very preterm infants born <32 weeks' gestation and most closely matches the population studied in our paper (i.e., babies born <32 weeks gestation in the UK). The PARCA-R has been shown to have concurrent validity with gold standard developmental tests and diagnostic utility for identifying infants with developmental delay in numerous cohorts [9] [10] [11] . The time taken to complete the two parts of the questionnaire has been estimated at around 15 minutes and generally, where attempted, is completed easily with few items left blank 12 13 . 
RESULTS
Twenty-three Primary Care Trusts (PCTs; the commissioning bodies when the study was established) and 30 participating hospitals were situated within the study area. A large number of babies received care in more than one hospital. For individual PCTs, the highest number of potential cases in any one year was 85 and the lowest was 4. Aggregated data are therefore presented.
There was little variation in the numbers of eligible babies in each of the five years for which data are presented and >4000 over the 5 years (Table 2) .
Prospective consent was sought during 2009, 2010 and 2011. In 2009, 102 babies were excluded from the study primarily because the required hospital permission processes and approvals were not in place at the time of discharge. The rate of consent to participate in follow-up showed a steady increase over time to 83.1% in 2011 when the study was accepted onto the NIHR portfolio. However despite this increase in early parental consent, the eventual response rate in terms of completion and return of questionnaires as a proportion of those eligible at two years showed little change overtime varying between 42% and 46%. Amongst parents that provided prospective consent the rate of return of completed forms was initially 63.2% but fell to 51.8% by the end of the study.
Findings from assessment forms that were returned are summarised for the whole population in We wished to assess whether the Oxford Minimum Dataset and the PARCA-R identified different children, to determine whether those with motor or sensory disability also performed poorly on the PARCA-R. This comparison is shown in Table  4 . Although there is overlap in the children identified with problems, a significant number of children are detected with problems by one of the two screening tests but not by both. 
DISCUSSION
Outcome data at 2 years regarding the survivors of neonatal intensive care has long been considered an important quality measure. Given the financial constraints within the NHS this study aimed to assess a cost-effective method of collecting such data that could be done on a routine basis, and we believe represents a first in the UK. However the overall response rate in this study was disappointing. Considering the eligible population in each year as a whole, completed questionnaires were returned for less than half the children in any of the five years. Surprisingly the percentage of returned forms was highest in 2007 when information was requested without any prior warning, suggesting parents' willingness to collaborate with this type of follow up may have declined over time, a finding duplicated in research studies of preterm babies and population-based cohorts more generally within the UK [13] [14] [15] indicating that the poor response does not relate simply to this particular combination of instruments. Amongst families who gave prospective consent response rates varied from 63% (2009) to 52% (2011).
We chose to use a score of 44 or less for the PARCA-R to identify potential cognitive deficits and we accept that alternative cut offs could have been more appropriate particularly if the aim is to identify severe rather than moderate/severe disability. However the results make clear that even when using a cut-off score of 44 the PARCA-R is largely identifying a different group of children to those with other forms of disability. This underscores the need to assess multiple developmental domains to identify those with potential long term problems.
Strengths and limitations
A number of factors may have contributed to the disappointing response rate. One possibility is poor communication between the research team and the families, but the fact that the system worked successfully for many families makes this seem unlikely. In addition, the population that was the focus of the study is very well known to the researchers involved. A single part time administrator ensured that questionnaires and reminders were sent to parents and hence, there was no personalised "chasing" of non-responders. Providing this may have increased the response rate but would have substantially increased the expense associated with the study, and it had been agreed with commissioners that a low cost approach would be assessed i.e. a method with potential to be used routinely by the NHS.
The main aim of our study was to obtain data relevant to the quality improvement agenda, with feedback of the findings to both providers and Commissioners. As such there was no feedback to parents and no incentive, as the system was run as simply and cheaply as possible. The method we employed therefore provided no potential benefit for the child or family. It may be that, for many families, the motivation simply to provide information about their child's health status was poor compared with other inevitable calls on their time. It is also important to note that, within the context of our study, questionnaire follow-up was not intended to replace clinical follow-up and ran in parallel with systems already in place in participating hospitals.
We chose to use a combination of questionnaires that we believed could simply and effectively provide a full picture of the child's health status and the results of this study show that a combination of measures is indeed needed to identify all those with developmental impairment at two years. However, some aspects of the questionnaires may have represented a challenge for parents who were less able intellectually or from ethnic minorities and whose first language was not English. We have considered previously whether the use of an online system of completion would have enhanced the response 16 .
Implications for practice
The study described here was developed primarily to identify a cost effective means of providing data that Commissioners could use to monitor care quality. Since data collection commenced for this study, having a system in place to monitor health status at two years has become a CQUIN (Commissioning for Quality and Innovation) for neonatal care. However it may well be that it was this limited aim of simply providing audit data that led to the lack of engagement with some families. In the future, it would seem sensible that any process to collect routine later health status data should, at the very least, have a means of providing feedback to parents about the results and the potential for clinical consultation for those with emergent parental concerns or screening positive for developmental problems. Having the child and family at the centre of a process that provides standardised "care quality information" as a natural bi-product seems much more likely to meet with parental engagement.
When considering alternative approaches to collecting this type of information in the future it may be important to recognise the potential for replication of developmental assessments that some children and their families may face. For "high risk" births there will normally be a period of routine clinical follow up in outpatient clinics perhaps culminating in some formal developmental assessment process. In addition, the child's health visitor will also assess the child's health status as he or she grows as part of the Health Child Programme, which from September 2015 will include a request for parents to complete a developmental screening questionnaire. These systems currently run in parallel and efforts to integrate and standardise these assessments may improve patient engagement with routine developmental screening and follow-up for their child. Certainly there is evidence that the relevant Government Departments are actively looking for ways to harmonise the various approaches to assessment currently in place (http://www.foundationyears.org.uk/files/2013/11/Information_Sharing_in_the_Found ation_Years_Report_FINAL.pdf ; http://www.local.gov.uk/health/-/journal_content/56/10180/5886759/ARTICLE).
.
CONCLUSIONS
It appears that further work is needed to establish a low cost means of obtaining data for routine reporting of health status in high-risk preterm babies. Simply requesting data for this purpose alongside existing follow-up does not appear to be effective. A process focused on the individual child's needs that is part of an existing surveillance programme and which, as a by-product, generates the required information may be an appropriate way forward. However, it seems reasonable to consider testing the effectiveness of questionnaire based follow-up in those groups where large numbers preclude formal outpatient follow-up from birth, such as babies born late or moderate preterm, despite evidence of significant rates of adverse outcomes at and beyond two years.
